Literature DB >> 1209475

Separate inguinal incisions in the treatment of carcinoma of the vulva.

S C Ballon, E J Lamb.   

Abstract

A modified surgical technique, using separate incisions for vulvectomy and for each groin, resulted in a low morbidity rate, with no increase in tumor recurrence and no reduction in length of survival time in comparison with previously reported methods of treatment of invasive squamous carcinoma of the vulva. The clinical staging adopted by the International Federation of Gynaecology and Obstetrics accurately predicted survival time for patients in this series as in others. However, in instances in which the histologic status of the nodes differs from the clinical assessment, postsurgical staging with primary importance attached to the histologic evaluation more accurately predicts prognosis.

Entities:  

Mesh:

Year:  1975        PMID: 1209475

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Groin lymphadenectomy with preservation of femoral fascia: total inguinofemoral node dissection for treatment of vulvar carcinoma.

Authors:  Leonardo Micheletti; Fabrizio Bogliatto; Marco Massobrio
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

Review 2.  "Unresectable" vulval cancers: is neoadjuvant chemotherapy the way forward?

Authors:  Kathryn Graham; Kevin Burton
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

3.  Colposcopy in the follow-up of women with lower genital tract or perianal carcinoma.

Authors:  S C Ballon
Journal:  Can Med Assoc J       Date:  1976-02-21       Impact factor: 8.262

4.  [Lymphadenectomy of the inguinal region and pelvis].

Authors:  P M Vogt; L-W Lahoda; M Meyer-Marcotty; M Spies; K H Busch
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

Review 5.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.